These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 22634710

  • 1. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR.
    Watanabe T, Suzuki T, Natsume M, Nakajima M, Narumi K, Hamada S, Sakuma T, Koeda A, Oshida K, Miyamoto Y, Maeda A, Hirayama M, Sanada H, Honda H, Ohyama W, Okada E, Fujiishi Y, Sutou S, Tadakuma A, Ishikawa Y, Kido M, Minamiguchi R, Hanahara I, Furihata C.
    Mutat Res; 2012 Sep 18; 747(2):164-75. PubMed ID: 22634710
    [Abstract] [Full Text] [Related]

  • 2. Differential gene expression profiling between genotoxic and non-genotoxic hepatocarcinogens in young rat liver determined by quantitative real-time PCR and principal component analysis.
    Suenaga K, Takasawa H, Watanabe T, Wako Y, Suzuki T, Hamada S, Furihata C.
    Mutat Res; 2013 Feb 18; 751(1):73-83. PubMed ID: 23183053
    [Abstract] [Full Text] [Related]

  • 3. Using RNA-Seq with 11 marker genes to evaluate 1,4-dioxane compared with typical genotoxic and non-genotoxic rat hepatocarcinogens.
    Furihata C, Toyoda T, Ogawa K, Suzuki T.
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Oct 18; 834():51-55. PubMed ID: 30173864
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dose-dependent alterations in gene expression in mouse liver induced by diethylnitrosamine and ethylnitrosourea and determined by quantitative real-time PCR.
    Watanabe T, Tanaka G, Hamada S, Namiki C, Suzuki T, Nakajima M, Furihata C.
    Mutat Res; 2009 Feb 19; 673(1):9-20. PubMed ID: 19100860
    [Abstract] [Full Text] [Related]

  • 6. Collaborative studies in toxicogenomics in rodent liver in JEMS·MMS; a useful application of principal component analysis on toxicogenomics.
    Furihata C, Watanabe T, Suzuki T, Hamada S, Nakajima M.
    Genes Environ; 2016 Feb 19; 38():15. PubMed ID: 27482301
    [Abstract] [Full Text] [Related]

  • 7. Using FFPE RNA-Seq with 12 marker genes to evaluate genotoxic and non-genotoxic rat hepatocarcinogens.
    Furihata C, You X, Toyoda T, Ogawa K, Suzuki T.
    Genes Environ; 2020 Feb 19; 42():15. PubMed ID: 32256870
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ.
    Mutat Res; 2005 Aug 04; 575(1-2):61-84. PubMed ID: 15890375
    [Abstract] [Full Text] [Related]

  • 9. Short-term in vivo testing to discriminate genotoxic carcinogens from non-genotoxic carcinogens and non-carcinogens using next-generation RNA sequencing, DNA microarray, and qPCR.
    Furihata C, Suzuki T.
    Genes Environ; 2023 Feb 09; 45(1):7. PubMed ID: 36755350
    [Abstract] [Full Text] [Related]

  • 10. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY, Ellinger-Ziegelbauer H, Vinken M, Vanhaecke T, van Delft J, Kleinjans J, Ahr HJ, Rogiers V.
    Arch Toxicol; 2012 Sep 09; 86(9):1399-411. PubMed ID: 22484513
    [Abstract] [Full Text] [Related]

  • 11. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens.
    Koufaris C, Wright J, Currie RA, Gooderham NJ.
    Toxicol Sci; 2012 Aug 09; 128(2):532-43. PubMed ID: 22584684
    [Abstract] [Full Text] [Related]

  • 12. Characteristic expression profiles induced by genotoxic carcinogens in rat liver.
    Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ.
    Toxicol Sci; 2004 Jan 09; 77(1):19-34. PubMed ID: 14600272
    [Abstract] [Full Text] [Related]

  • 13. Identification of biomarkers of chemically induced hepatocarcinogenesis in rasH2 mice by toxicogenomic analysis.
    Park HJ, Oh JH, Park SM, Cho JW, Yum YN, Park SN, Yoon DY, Yoon S.
    Arch Toxicol; 2011 Dec 09; 85(12):1627-40. PubMed ID: 21607683
    [Abstract] [Full Text] [Related]

  • 14. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling.
    van Delft JH, van Agen E, van Breda SG, Herwijnen MH, Staal YC, Kleinjans JC.
    Mutat Res; 2005 Aug 04; 575(1-2):17-33. PubMed ID: 15924884
    [Abstract] [Full Text] [Related]

  • 15. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
    Uehara T, Hirode M, Ono A, Kiyosawa N, Omura K, Shimizu T, Mizukawa Y, Miyagishima T, Nagao T, Urushidani T.
    Toxicology; 2008 Aug 19; 250(1):15-26. PubMed ID: 18619722
    [Abstract] [Full Text] [Related]

  • 16. Identification of early target genes of aflatoxin B1 in human hepatocytes, inter-individual variability and comparison with other genotoxic compounds.
    Josse R, Dumont J, Fautrel A, Robin MA, Guillouzo A.
    Toxicol Appl Pharmacol; 2012 Jan 15; 258(2):176-87. PubMed ID: 22100608
    [Abstract] [Full Text] [Related]

  • 17. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
    Kim JY, Kwon J, Kim JE, Koh WS, Chung MK, Yoon S, Song CW, Lee M.
    Environ Mol Mutagen; 2005 Jan 15; 45(1):80-9. PubMed ID: 15612046
    [Abstract] [Full Text] [Related]

  • 18. Prediction model of potential hepatocarcinogenicity of rat hepatocarcinogens using a large-scale toxicogenomics database.
    Uehara T, Minowa Y, Morikawa Y, Kondo C, Maruyama T, Kato I, Nakatsu N, Igarashi Y, Ono A, Hayashi H, Mitsumori K, Yamada H, Ohno Y, Urushidani T.
    Toxicol Appl Pharmacol; 2011 Sep 15; 255(3):297-306. PubMed ID: 21784091
    [Abstract] [Full Text] [Related]

  • 19. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies.
    Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ.
    Mutat Res; 2008 Jan 01; 637(1-2):23-39. PubMed ID: 17689568
    [Abstract] [Full Text] [Related]

  • 20. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells.
    Harris AJ, Dial SL, Casciano DA.
    Mutat Res; 2004 May 18; 549(1-2):79-99. PubMed ID: 15120964
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.